Trimbow | 合法藥品大搜索

Inasthma,Trimbowisusedformaintenancetreatmentinadultswhosediseaseisnotadequatelycontrolleddespitetreatmentwithalong-actingbeta-2agonist ...

COPD Trimbow has been shown to be effective at relieving symptoms of COPD in three main studies involving over 5,500 patients whose symptoms were not controlled well enough either by combinations of two other COPD medicines or by a long-acting muscarinic receptor antagonist alone. 

In the first study lasting a year, after 26 weeks of treatment Trimbow improved patients’ FEV1 (the maximum volume of air a person can breathe out in one second) by 82 ml before a dose and 261 ml after a dose. By comparison, the FEV1 increased by 1 and 145 ml before and after dosing in patients treated with a medicine containing only 2 of the active substances[1] found in Trimbow (beclometasone plus formoterol). 

In the second study lasting a year, patients treated with Trimbow had 20% fewer exacerbations (flare-ups of symptoms) a year than patients treated with tiotropium (a long-acting muscarinic ...